PDS Biotechnology (PDSB) Short Interest Ratio & Short Volume $1.34 -0.08 (-5.63%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.41 +0.07 (+5.22%) As of 02/21/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PDS Biotechnology Short Interest DataPDS Biotechnology (PDSB) has a short interest of 4.01 million shares. This marks a -2.43% decrease in short interest from the previous month. The short interest ratio (days to cover) is 10.6, indicating that it would take 10.6 days of the average trading volume of 246,637 shares to cover all short positions.Current Short Interest4,010,000 sharesPrevious Short Interest4,110,000 sharesChange Vs. Previous Month-2.43%Dollar Volume Sold Short$6.58 millionShort Interest Ratio10.6 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares37,410,000 sharesPercentage of Shares Shorted10.72%Today's Trading Volume185,456 sharesAverage Trading Volume246,637 sharesToday's Volume Vs. Average75% Short Selling PDS Biotechnology? Sign up to receive the latest short interest report for PDS Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPDSB Short Interest Over TimePDSB Days to Cover Over TimePDSB Percentage of Float Shorted Over Time PDS Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20254,010,000 shares $6.58 million -2.4%N/A10.6 $1.64 1/15/20254,110,000 shares $5.96 million +1.2%N/A10.3 $1.45 12/31/20244,060,000 shares $6.62 million -4.0%N/A10.1 $1.63 12/15/20244,230,000 shares $7.78 million +9.0%N/A9.5 $1.84 11/30/20243,880,000 shares $8.50 million +0.3%N/A9.2 $2.19 11/15/20243,870,000 shares $7.78 million -13.4%N/A9.9 $2.01 10/31/20244,470,000 shares $14.26 million -6.9%N/A14.3 $3.19 10/15/20244,800,000 shares $15.50 million +0.2%N/A16.1 $3.23 9/30/20244,790,000 shares $18.30 million +3.9%N/A14.2 $3.82 9/15/20244,610,000 shares $13.83 million -3.2%N/A11.2 $3.00 Get the Latest News and Ratings for PDSB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PDS Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 8/31/20244,760,000 shares $15.23 million -5.4%N/A10.7 $3.20 8/15/20245,030,000 shares $16.25 million -0.8%N/A10.4 $3.23 7/31/20245,070,000 shares $18.05 million -11.1%N/A8.8 $3.56 7/15/20245,700,000 shares $24.08 million -18.6%N/A9.1 $4.23 6/30/20247,000,000 shares $20.51 million +3.7%N/A10.4 $2.93 6/15/20246,750,000 shares $18.80 million +0.6%N/A8.7 $2.79 5/31/20246,710,000 shares $20.00 million -2.0%N/A8.2 $2.98 5/15/20246,850,000 shares $23.98 million -0.2%N/A7.3 $3.50 4/30/20246,860,000 shares $22.98 million -3.9%N/A7.6 $3.35 4/15/20247,140,000 shares $20.13 million +16.1%N/A7.7 $2.82 3/31/20246,150,000 shares $24.35 million +11.6%N/A6.7 $3.96 3/15/20245,510,000 shares $27.00 million +9.5%N/A7 $4.90 2/29/20245,030,000 shares $33.15 million +0.4%N/A7.1 $6.59 2/15/20245,010,000 shares $27.35 million -5.1%N/A8.4 $5.46 1/31/20245,280,000 shares $28.25 million +1.9%N/A8.6 $5.35 1/15/20245,180,000 shares $22.38 million +5.5%N/A9.2 $4.32 12/31/20234,910,000 shares $24.40 million +4.7%N/A9.8 $4.97 12/15/20234,690,000 shares $23.92 million -3.5%N/A9 $5.10 11/30/20234,860,000 shares $25.56 million -7.4%N/A9.9 $5.26 11/15/20235,250,000 shares $33.18 million -4.9%N/A11.3 $6.32 10/31/20235,520,000 shares $23.02 million -6.3%N/A12 $4.17 10/15/20235,890,000 shares $26.56 million +11.8%N/A12.3 $4.51 9/30/20235,270,000 shares $26.61 million +15.3%N/A9.9 $5.05 9/15/20234,570,000 shares $24.40 million +6.5%N/A7.9 $5.34 8/31/20234,290,000 shares $25.18 million +7.8%N/A6.4 $5.87 8/15/20233,980,000 shares $23.40 million +0.5%N/A3.9 $5.88 7/31/20233,960,000 shares $22.63 million -5.5%N/A4.3 $5.72 7/15/20234,190,000 shares $21.49 million +8.0%N/A4.7 $5.13 6/30/20233,880,000 shares $19.52 million +32.0%N/A4.5 $5.03 6/15/20232,940,000 shares $18.29 million +9.7%N/A3.5 $6.22Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y 5/31/20232,680,000 shares $25.67 million +27.0%N/A3.9 $9.58 5/15/20232,110,000 shares $14.62 million No ChangeN/A6.1 $6.93 4/30/20232,110,000 shares $12.83 million +3.4%N/A5.9 $6.08 4/15/20232,040,000 shares $14.06 million +2.5%N/A4.9 $6.89 3/31/20231,990,000 shares $12.24 million +7.6%N/A4.3 $6.15 3/15/20231,850,000 shares $12.27 million +1.7%N/A3.1 $6.63 2/28/20231,820,000 shares $13.92 million +15.2%N/A3 $7.65 2/15/20231,580,000 shares $13.84 million -3.7%N/A2.5 $8.76 1/31/20231,640,000 shares $13.66 million +9.3%N/A1.6 $8.33 1/15/20231,500,000 shares $15.57 million +5.6%N/A1.5 $10.38 12/30/20221,420,000 shares $18.74 million +34.0%N/A1.4 $13.20 12/15/20221,060,000 shares $10.01 million -2.8%N/A1.3 $9.44 11/30/20221,090,000 shares $9.84 million -26.4%N/A1.4 $9.03 11/15/20221,480,000 shares $12.85 million +5.7%N/A2.1 $8.68 10/31/20221,400,000 shares $7.34 million +6.9%N/A5.7 $5.24 10/15/20221,310,000 shares $5.23 million +0.8%N/A5.4 $3.99 9/30/20221,300,000 shares $3.86 million -6.5%N/A5.9 $2.97 9/15/20221,390,000 shares $5.45 million -6.1%N/A6 $3.92 8/31/20221,480,000 shares $6.20 million -1.3%N/A5.3 $4.19 8/15/20221,500,000 shares $8.69 million -10.2%N/A2.4 $5.79 7/31/20221,670,000 shares $7.15 million -5.1%N/A2.5 $4.28 7/15/20221,760,000 shares $7.00 million -6.9%N/A2.7 $3.98 6/30/20221,890,000 shares $6.90 million +0.5%N/A3 $3.65 6/15/20221,880,000 shares $6.07 million +20.5%N/A3 $3.23 5/31/20221,560,000 shares $6.12 million +4.0%N/A2.6 $3.92 5/15/20221,500,000 shares $6.84 million +2.0%N/A5.6 $4.56 4/30/20221,470,000 shares $8.13 million +1.4%N/A5.8 $5.53 4/15/20221,450,000 shares $8.12 million +0.7%N/A4.6 $5.60 3/31/20221,440,000 shares $8.91 million +0.7%N/A4.2 $6.19 3/15/20221,430,000 shares $7.81 million +14.4%N/A4 $5.46 2/28/20221,250,000 shares $7.48 million +50.7%N/A3.2 $5.98 2/15/2022829,500 shares $5.72 million +32.5%N/A2.1 $6.90 1/31/2022625,900 shares $3.73 million -5.5%N/A1.5 $5.96 1/15/2022662,000 shares $4.51 million +4.8%N/A1.8 $6.82 12/31/2021631,600 shares $5.12 million -10.6%N/A1.7 $8.10 12/15/2021706,800 shares $6.34 million +33.4%N/A1.7 $8.97 11/30/2021529,800 shares $5.22 million -26.5%N/A1.2 $9.85 11/15/2021720,300 shares $7.86 million -6.7%N/A1.6 $10.91 10/29/2021772,000 shares $9.29 million -5.0%N/A1.6 $12.04 10/15/2021812,700 shares $10.02 million +66.2%N/A1.7 $12.33 9/30/2021489,100 shares $7.29 million +10.2%N/A1 $14.90 9/15/2021443,900 shares $6.79 million -1.6%N/A0.8 $15.30 8/31/2021451,100 shares $7.01 million +11.9%2.0%0.5 $15.55 8/13/2021403,200 shares $4.29 million -19.3%1.8%0.4 $10.65 7/30/2021499,600 shares $5.33 million -18.7%2.3%0.3 $10.67 7/15/2021614,500 shares $6.00 million -26.5%2.9%0.3 $9.77 6/30/2021836,400 shares $10.50 million -31.4%4.2%0.5 $12.55 6/15/20211,220,000 shares $11.22 million +20.8%5.6%0.7 $9.20 5/28/20211,010,000 shares $12.32 million +18.8%5.7%0.5 $12.20 5/14/2021850,500 shares $3.81 million +27.8%N/A0.4 $4.48Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y 4/30/2021665,600 shares $3.80 million -29.0%N/A0.4 $5.71 4/15/2021937,100 shares $4.92 million +207.3%N/A0.6 $5.25 3/31/2021305,000 shares $1.30 million -62.6%N/A0.2 $4.25 3/15/2021816,300 shares $4.61 million +73.6%N/A0.5 $5.65 2/26/2021470,300 shares $2.09 million +38.8%N/A0.5 $4.45 2/12/2021338,900 shares $1.90 million -26.2%N/A0.4 $5.61 1/29/2021458,900 shares $1.18 million +19.2%N/A0.6 $2.57 1/15/2021385,100 shares $1.06 million -40.7%N/A0.8 $2.76 12/31/2020648,900 shares $1.45 million +39.4%N/A1.4 $2.23 12/15/2020465,400 shares $981,994.00 +8.1%N/A1 $2.11 11/30/2020430,400 shares $912,448.00 +10.5%N/A0.9 $2.12 11/15/2020389,600 shares $798,680.00 +10.9%N/A1 $2.05 10/30/2020351,300 shares $751,782.00 +66.8%N/A0.6 $2.14 10/15/2020210,600 shares $494,910.00 -32.1%N/A0.3 $2.35 9/30/2020310,000 shares $722,300.00 -42.8%N/A0.3 $2.33 9/15/2020542,000 shares $1.36 million -22.9%N/A0.3 $2.51 8/31/2020702,900 shares $1.71 million +0.8%N/A0.4 $2.43 8/14/2020697,200 shares $1.95 million -1.5%N/A0.4 $2.79 7/31/2020708,100 shares $2.59 million +4.9%N/A0.4 $3.66 7/15/2020675,200 shares $1.38 million +279.8%N/A0.4 $2.04 6/30/2020177,800 shares $357,378.00 +389.8%N/A0.1 $2.01 6/15/202036,300 shares $47,190.00 +32.0%N/A0 $1.30 5/29/202027,500 shares $34,375.00 +17.0%N/A0 $1.25 5/15/202023,500 shares $20,846.85 -56.4%N/A0 $0.89 4/30/202053,900 shares $51,205.00 +257.0%N/A0.1 $0.95 4/15/202015,100 shares $12,620.58 -66.4%N/A0 $0.84 3/31/202044,900 shares $42,655.00 -38.0%N/A0.3 $0.95 3/13/202072,400 shares $52,128.00 +46.0%N/A0.7 $0.72 2/28/202049,600 shares $34,720.00 -53.3%N/A0.5 $0.70 PDSB Short Interest - Frequently Asked Questions What is PDS Biotechnology's current short interest? Short interest is the volume of PDS Biotechnology shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 4,010,000 shares of PDSB short. Learn More on PDS Biotechnology's current short interest. What is a good short interest ratio for PDS Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PDSB shares currently have a short interest ratio of 11.0. Learn More on PDS Biotechnology's short interest ratio. Which institutional investors are shorting PDS Biotechnology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of PDS Biotechnology: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is PDS Biotechnology's short interest increasing or decreasing? PDS Biotechnology saw a drop in short interest in January. As of January 31st, there was short interest totaling 4,010,000 shares, a drop of 2.4% from the previous total of 4,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does PDS Biotechnology's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to PDS Biotechnology: LifeVantage Co. (5.91%), Voyager Therapeutics, Inc. (4.78%), Design Therapeutics, Inc. (10.06%), 4D Molecular Therapeutics, Inc. (16.01%), Lifecore Biomedical, Inc. (7.52%), C4 Therapeutics, Inc. (10.48%), Cardiff Oncology, Inc. (20.44%), Acelyrin, Inc. (8.09%), Larimar Therapeutics, Inc. (7.95%), Ocugen, Inc. (20.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short PDS Biotechnology stock? Short selling PDSB is an investing strategy that aims to generate trading profit from PDS Biotechnology as its price is falling. PDSB shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PDS Biotechnology? A short squeeze for PDS Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PDSB, which in turn drives the price of the stock up even further. How often is PDS Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PDSB, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies LifeVantage Short Squeeze Voyager Therapeutics Short Squeeze Design Therapeutics Short Squeeze 4D Molecular Therapeutics Short Squeeze Lifecore Biomedical Short Squeeze C4 Therapeutics Short Squeeze Cardiff Oncology Short Squeeze Acelyrin Short Squeeze Larimar Therapeutics Short Squeeze Ocugen Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PDSB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDS Biotechnology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PDS Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PDSB Stock Alerts